Due: Nov 5, 2027
Due: Nov 19, 2026
Due: Nov 16, 2027
Rolling Submissions
Support for investigational new drug (IND)-enabling studies and early-phase clinical trials testing promising interventions for Alzheimer's disease and related dementias Letter of Intent due on various dates in 2024: